642
Views
1
CrossRef citations to date
0
Altmetric
Non-neutralizing protective antibodies

HIV-1 Env DNA prime plus gp120 and gp70-V1V2 boosts induce high level of V1V2-specific IgG and ADCC responses and low level of Env-specific IgA response: implication for improving RV144 vaccine regimen

, , , , , , , & show all
Pages 1-4 | Received 02 May 2017, Accepted 10 Oct 2017, Published online: 15 Jan 2019

References

  • Medlock J, Pandey A, Parpia ASet al.Effectiveness of UNAIDS targets and HIV vaccination across 127 countries. Proc Natl Acad Sci USA 2017;114: 4017–4022.
  • Fauci AS, Marston HD.Focusing to achieve a world without AIDS. JAMA 2015;313: 357–358.
  • Kim JH, Excler JL, Michael NL.Lessons from the RV144 Thai phase III HIV-1 vaccine trial and the search for correlates of protection. Annu Rev Med 2015;66: 423–437.
  • Lelievre JD, Levy Y.HIV-1 prophylactic vaccines: state of the art. J Virus Erad 2016;2: 5–11.
  • Rerks-Ngarm S, Pitisuttithum P, Nitayaphan Set al.Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009;361: 2209–2220.
  • Haynes BF, Gilbert PB, McElrath MJet al.Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N Engl J Med 2012;366: 1275–1286.
  • Bruel T, Guivel-Benhassine F, Lorin Vet al.Lack of ADCC breadth of human nonneutralizing anti-HIV-1 antibodies. J Virol 2017;91: pii: e02440-16.
  • Pinter A, Honnen WJ, Kayman SCet al.Potent neutralization of primary HIV-1 isolates by antibodies directed against epitopes present in the V1/V2 domain of HIV-1 gp120. Vaccine 1998;16: 1803–1811.
  • Sun Z, Zhu Y, Wang Qet al.An immunogen containing four tandem 10E8 epitope repeats with exposed key residues induces antibodies that neutralize HIV-1 and activates an ADCC reporter gene. Emerg Microbes Infect 2016;5: e65.
  • Walker LM, Phogat SK, Chan-Hui PYet al.Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 2009;326: 285–289.
  • Bruel T, Guivel-Benhassine F, Amraoui Set al.Elimination of HIV-1-infected cells by broadly neutralizing antibodies. Nat Commun 2016;7: 10844.